Is an outbreak of inflammatory bowel disease (ulcerative colitis or Crohn's disease) more likely in patients prescribed a beta-lactam antibiotic or azithromycin?
Fuente:
Zenodo
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Recurso digital |
| Publicado: |
Zenodo
2026
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1866901491660357632 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | The evidence indicates an association between general antibiotic use and an increased risk of IBD, but there is insufficient specific evidence comparing the risk of IBD from beta-lactam antibiotics versus azithromycin. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_18466628 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Is an outbreak of inflammatory bowel disease (ulcerative colitis or Crohn's disease) more likely in patients prescribed a beta-lactam antibiotic or azithromycin? Tripdatabase inflammatory bowel disease ulcerative colitis Crohn's disease beta-lactam antibiotics azithromycin antibiotic use disease outbreak gastroenterology pharmacology risk factors The evidence indicates an association between general antibiotic use and an increased risk of IBD, but there is insufficient specific evidence comparing the risk of IBD from beta-lactam antibiotics versus azithromycin. |
| title | Is an outbreak of inflammatory bowel disease (ulcerative colitis or Crohn's disease) more likely in patients prescribed a beta-lactam antibiotic or azithromycin? |
| topic | inflammatory bowel disease ulcerative colitis Crohn's disease beta-lactam antibiotics azithromycin antibiotic use disease outbreak gastroenterology pharmacology risk factors |
| url | https://doi.org/10.5281/zenodo.18466628 |